上海医药
上海醫藥
상해의약
SHANGHAI MEDICAL & PHARMACEUTICAL JOURNAL
2015年
9期
58-63
,共6页
样本医院%医院用药%数据分析
樣本醫院%醫院用藥%數據分析
양본의원%의원용약%수거분석
sample hospital%hospital medication%data analysis
上海是我国进行首批医改试点的城市之一,由于地域经济发达、治疗水平领先、文化底蕴深厚与较强的自我保健意识决定了上海地区的用药特点。本文使用近5年上海地区样本医院药品购入总金额增长幅度与全国22城市地区样本医院的数据对比,从用药大类的份额占比变化、医院使用领先药品及主要供应商位序、药品的来源构成与生产商的主打品种等维度研究医院用药品种的变化及厂商的竞争情况。政策与制度的不断出台左右了上海地区医院用药,上海地区医院无论在用药水平、临床品种选取或药品来源的选择等方面都有其特殊性,招标规范与用药的合理性使合资药与国产药的竞争难分伯仲,目前销售领先的厂商及其主打品种的地位难以撼动。
上海是我國進行首批醫改試點的城市之一,由于地域經濟髮達、治療水平領先、文化底蘊深厚與較彊的自我保健意識決定瞭上海地區的用藥特點。本文使用近5年上海地區樣本醫院藥品購入總金額增長幅度與全國22城市地區樣本醫院的數據對比,從用藥大類的份額佔比變化、醫院使用領先藥品及主要供應商位序、藥品的來源構成與生產商的主打品種等維度研究醫院用藥品種的變化及廠商的競爭情況。政策與製度的不斷齣檯左右瞭上海地區醫院用藥,上海地區醫院無論在用藥水平、臨床品種選取或藥品來源的選擇等方麵都有其特殊性,招標規範與用藥的閤理性使閤資藥與國產藥的競爭難分伯仲,目前銷售領先的廠商及其主打品種的地位難以撼動。
상해시아국진행수비의개시점적성시지일,유우지역경제발체、치료수평령선、문화저온심후여교강적자아보건의식결정료상해지구적용약특점。본문사용근5년상해지구양본의원약품구입총금액증장폭도여전국22성시지구양본의원적수거대비,종용약대류적빈액점비변화、의원사용령선약품급주요공응상위서、약품적래원구성여생산상적주타품충등유도연구의원용약품충적변화급엄상적경쟁정황。정책여제도적불단출태좌우료상해지구의원용약,상해지구의원무론재용약수평、림상품충선취혹약품래원적선택등방면도유기특수성,초표규범여용약적합이성사합자약여국산약적경쟁난분백중,목전소수령선적엄상급기주타품충적지위난이감동。
Shanghai is one of the first batch of pilot cities to implement Chinese medical reform. The developed regional economy, leading therapeutic levels, rich cultural heritage and strong sense of self-care determine the medication characteristics of Shanghai. The change of drugs used in hospital and the competition status among manufacturers were studied by comparison of the data on the growth rate of total amount of drugs purchased in the sample hospitals of Shanghai in the past 5 years with those in 22 sample hospitals in other urban areas of China in terms of the change of the share of drug category, leading drugs from hospitals and a major supplier of rank and the sources of drugs and the manufacturer’s lfagship species. The drugs used in the sample hospitals of Shanghai were affected by the continuous introduction of the policies and institutions. The hospitals in Shanghai have their particularity in terms of the level of medication, the selection of the clinical varieties and the source of the drugs. There is no difference between the joint-stock and home-made drugs in doctor’s prescription behavior because of the standardization of bidding and the rational use of drugs. At present the dominant positions in the market are dififcult to beat for the lending pharmaceutical companies and their major products.